Global PET Radiotracers Market Size, Share & Trends Analysis Report, By Type (F 18 Fluoro-Dihydroxy-L-Phenylalanine (F-DOPA), F 18 FDG, F 18 Fluoroethyl-L-Tyrosine (FET), C-11 Methionine, C 11 Etomidate, and Others), By Application (Oncology, Cardiology, Infectious Diseases, and Others), Forecast (2022-2028)

The global PET radiotracers market is anticipated to grow at a CAGR of 9.0% during the forecast period (2022-2028). The chemical compounds that comprise more than one atom replaced by a radioisotope are defined as PET radiotracers that are delivered intravenously. Positron emission tomography (PET) radiotracers generally find their application in tracking the mechanism of a biological system, such as glucocorticoid synthesis, amino acid uptake, glucose metabolism, and other metabolic studies. The major factor driving the market growth is the rising penetration of nuclear medicines owing to the growing prevalence of cancer, cardiac, and neurological ailments. This is further coupled with the growing initiatives to lessen the demand-supply gap of Mo-99. The isotope Mo-99 is an element used in the production of technetium-99m (Tc-99m). Nearly 85% of medical imaging in nuclear medicine uses Tc-99m, which amounts to 17 million diagnostic procedures per year all over the globe.

According to the American Nuclear Society, over 10,000 hospitals globally use radioisotopes, where nearly 90% of these are used for the diagnosis of infectious diseases, neurological disorders, cancer, and other diagnostic applications. Among all these disorders, the growing prevalence of cancer and cardiovascular disease demands an effective solution such as PET radiotracers. According to the World Health Organization (WHO), 19.3 million new cancer cases annually are anticipated to be reported globally by 2025. As PET radiotracers play a significant role in cancer and other diseases’ diagnosis and treatment, the rising incidences of such diseases is likely to drive the growth of the global PET radiotracers market during the forecast period.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape: Alliance Medical, ABX GmbH, and Cambridge Isotope Laboratories, Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global PET Radiotracers Market Report by Segment

By Type

• F 18 Fluoro-Dihydroxy-L-Phenylalanine (F-DOPA)
• F 18 FDG
• F 18 Fluoroethyl-L-Tyrosine (FET)
• C-11 Methionine
• C 11 Etomidate
• Others

By Application

• Oncology
• Cardiology
• Infectious Diseases
• Others

Global PET Radiotracers Market Segmentation by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

 

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

 

Rest of the World

• Latin America
• Middle East and Africa